- Home
- GNTA vs MKTW Comparison
GNTA vs MKTW Comparison
Compare GNTA & MKTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNTA | MKTW |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.7M | 38.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GNTA | MKTW |
|---|---|---|
| Price | $1.42 | $15.77 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 122.9K | 8.5K |
| Earning Date | 03-30-2026 | 11-06-2025 |
| Dividend Yield | N/A | ★ 5.25% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.55 |
| Revenue | N/A | ★ $342,206,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $5.97 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.28 | $9.08 |
| 52 Week High | $10.00 | $21.74 |
Technical Indicators
Market Signals| Indicator | GNTA | MKTW |
|---|---|---|
| Relative Strength Index (RSI) | 35.61 | 36.36 |
| Support Level | $1.28 | $16.20 |
| Resistance Level | $1.77 | $16.10 |
| Average True Range (ATR) | 0.18 | 0.38 |
| MACD | 0.00 | -0.09 |
| Stochastic Oscillator | 22.78 | 0.00 |
Price Performance
Historical ComparisonAbout GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
About MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.